Ablation Technology Market Trend, Share, Growth, Size, Analysis and Forecast 2030

Table Of Content

Methodology

Free Analysis

The ablation technology is used for the treatment of several healthcare problems which include cancer, cardiovascular problems, orthopedics, pain management, urology, gynecology, and many others. The treatment based on the ablation technology involves negligible invasion along with the minimum damage to the tissues and organs surrounding the infected organ. The inclination of the patients towards the advanced technology based treatment which gives instant results with minimum side effects are projected to drive the ablation technology market over the forecast period. 

As per the World Health Organization, cardiovascular diseases are one of the main causes of death worldwide. About 17.5 million people died due to cardiovascular disease in 2015 representing 31% of all global deaths. Additionally, as per the World Health Organization estimates, 8.8 million deaths resulted due to cancer in 2015. Globally, approximately 1 in 6 deaths is because of cancer. Also, the global burden of these disorders is increasing further owing to the increasing geriatric population base across the world. According to the World Health Organization, the number of people who aged 60 or above is expected to be doubled by 2050 growing from 962 million globally in 2017 to 2.1 billion in 2050. Thus, ablation technology market has vast potential in terms of large patient pool and upsurge need for significant treatment.

The ablation technology market is segmented on the basis of product type as hydrothermal, microwave, cryotherapy, electrical, laser, ultrasound and the radiofrequency. By product, the radiofrequency segment is estimated to cover the maximum market value share due to its comparatively lower price as compared to the other technologies which make it more preferable for the patients.

Based on application, ablation technology is segmented as cancer, cardiovascular, orthopedics, pain management, urology, gynecology, and others. By application, cancer is expected to occupy the largest market value share due to the increasing cases of cancer which has created the upsurge need for the treatment.
 
Based on end-use, ablation technology is segmented as hospitals, clinics, and others. By end user, the hospital segment is estimated to be the prominent segment and will show significant CAGR growth over estimated time.

North America is anticipated to be the dominant region in the ablation technology market over the forecast period. Favorable government policies supporting the invasion of new and advanced procedures for the treatment, development in the healthcare infrastructure, and research granted by the government and ruling authorities are expected to propel the growth of the ablation technology market in this region. Europe is the second largest market followed by the Asia Pacific. Increasing geriatric population base in the Asia Pacific region, especially India, China, and Japan is the significant accelerating factor for the growth of the ablation technology market in this region. Asia Pacific is expected to show the fastest CAGR growth during the forecast period while Latin America market is projected to grow at a low to moderate rate during the forecast period. The Middle East and Africa are also expected to cover the prominent market value share in the ablation technology global market.

Some of the key players in ablation technology market include Johnson & Johnson, Boston Scientific Corporation, Medtronic plc, Medical, Inc., Olympus Corporation, Conmed Corporation, AtriCure, Inc., AngioDynamics, Inc., BTG plc, Stryker Corporation, Hologic, Inc., Misonix, Inc, Elekta AB., EDAP TMS S.A., Terumo Corporation, Abbott Laboratories, Integra Life Sciences Holdings Corporation, Merit Medical Systems, Halyard Health, Inc. and Japan Lifeline Co., Ltd., among others.